TRPC4 Inactivation Confers a Survival Benefit in Severe Pulmonary Arterial Hypertension-Reference-Cited by-同舟云学术

TRPC4 Inactivation Confers a Survival Benefit in Severe Pulmonary Arterial Hypertension

Published:2013-12 Issue:6 Volume:183 Page:1779-1788
ISSN:0002-9440
Container-title:The American Journal of Pathology
language:en
Short-container-title:The American Journal of Pathology

Author:

Alzoubi Abdallah,Almalouf Philip,Toba Michie,O'Neill Kealan,Qian Xun,Francis Michael,Taylor Mark S.,Alexeyev Mikhail,McMurtry Ivan F.,Oka Masahiko,Stevens Troy

Publisher

Elsevier BV

Subject

Pathology and Forensic Medicine

Reference49 articles.

1. Updated clinical classification of pulmonary hypertension;Simonneau;J Am Coll Cardiol,2009

2. Pathogenic mechanisms of pulmonary arterial hypertension;Chan;J Mol Cell Cardiol,2008

3. Cellular and molecular basis of pulmonary arterial hypertension;Morrell;J Am Coll Cardiol,2009

4. Prognosis of pulmonary arterial hypertension: ACCP evidence-based clinical practice guidelines;McLaughlin;Chest,2004

5. Long-term response to calcium channel blockers in idiopathic pulmonary arterial hypertension;Sitbon;Circulation,2005

Cited by 39 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. TRPC4 aggravates hypoxic pulmonary hypertension by promoting pulmonary endothelial cell apoptosis;Free Radical Biology and Medicine;2024-07

2. TRP channels in cardiovascular disease;TRP Channels as Therapeutic Targets;2024

3. Mechanosensitive channels in lung disease;Frontiers in Physiology;2023-11-15

4. Pentastatin, a matrikine of the collagen IVα5, is a novel endogenous mediator of pulmonary endothelial dysfunction;American Journal of Physiology-Cell Physiology;2023-11-01

5. Contribution of transient receptor potential canonical channels in human and experimental pulmonary arterial hypertension;American Journal of Physiology-Lung Cellular and Molecular Physiology;2023-08-01